2022
DOI: 10.1007/s13402-022-00761-x
|View full text |Cite
|
Sign up to set email alerts
|

Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 47 publications
0
4
0
Order By: Relevance
“…S1 cleavage of the Notch receptor is necessary for Notch receptor maturation. Furin-like convertase is the protease for the S1 cleavage site [26] . S1 furin-like cleavage in the Golgi is regulated by Botch, and NICD is increased after treatment with furin [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…S1 cleavage of the Notch receptor is necessary for Notch receptor maturation. Furin-like convertase is the protease for the S1 cleavage site [26] . S1 furin-like cleavage in the Golgi is regulated by Botch, and NICD is increased after treatment with furin [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Fluorogenic furin substrate peptide (Pyr-Arg-Thr-Lys-Arg-AMC; Univ, Shanghai, China) was used to measure furin-like proprotein convertase activity. The experiment was performed as described in previous studies [ 25 , 26 ]. Briefly, Cell lysates were thawed on ice and diluted 2-fold using 5× lysis/reaction buffer, then 20 μL was added to black opaque 96-well plates (Corning, Corning, USA) containing 70 μL of ultrapure water.…”
Section: Methodsmentioning
confidence: 99%
“… 24 Notch1 ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1 mice Chen et al. 25 AGR3 anterior gradient 3 promotes breast cancer metastasis to liver and bone and chemotherapy response human Xu et al. 26 ER estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis mice Qureshi et al.…”
Section: Factors Contributing To Drug Resistance In Bclmmentioning
confidence: 99%
“…Much research has indicated that Ezrin overexpression is strongly associated with tumor metastasis and poor patient prognosis, acting as a key player in various cancer types. This has been observed in rhabdomyosarcoma (RMS) [ 215 ], breast cancer [ 220 , 221 ], PDAC [ 202 ], melanoma [ 36 ], ESCC [ 222 ], prostate cancer [ 223 ], and nasopharyngeal carcinoma [ 224 ], among others. Ezrin is abundantly expressed in highly metastatic cells in RMS compared to poorly metastatic cells [ 215 ].…”
Section: Ezrin As a Target For Treating Metastatic Diseasementioning
confidence: 99%